RNAC
Cartesian Therapeutics Inc.
NASDAQ: RNAC · HEALTHCARE · BIOTECHNOLOGY
$6.22
-3.86% today
Updated 2026-04-30
Market cap
$199.26M
P/E ratio
—
P/S ratio
71.24x
EPS (TTM)
$-5.02
Dividend yield
—
52W range
$6 – $16
Volume
0.2M
Cartesian Therapeutics Inc. (RNAC) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-59.8%
Last 4 quarters
Revenue YoY growth
-224.8%
Most recent quarter
EPS YoY growth
-356.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+13.7%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+24.8%
2026-03-09
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-09 | $-2.71 | -242.6% | $6.85 | $8.55 | +24.8% |
| 2025-11-06 | $-1.38 | -53.3% | $7.67 | $7.87 | +2.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.79 | $-2.71 | -242.6% | $947000.00 | -224.8% |
| 2025-09-30 | $-0.90 | $-1.38 | -53.3% | $452000.00 | +16.8% |
| 2025-06-30 | $-0.82 | $-0.77 | +5.8% | $298000.00 | -99.1% |
| 2025-03-31 | $-0.71 | $-0.65 | +8.5% | $1.10M | -81.2% |
| 2024-12-31 | $-0.83 | $-0.59 | +28.1% | $-759000.00 | -109.2% |
| 2024-09-30 | $-0.55 | $-0.42 | +23.6% | $387000.00 | -94.1% |
| 2024-06-30 | $-0.09 | $0.64 | +811.1% | $33.45M | +537.2% |
| 2024-03-31 | $-1.42 | $-0.80 | +43.7% | $5.84M | -1.7% |
| 2023-12-31 | $-0.04 | $-0.07 | -75.0% | $8.27M | — |
| 2023-09-30 | $-0.06 | $-0.06 | +0.0% | $6.55M | — |
| 2023-06-30 | $-0.08 | $-0.07 | +12.5% | $5.25M | — |
| 2023-03-31 | $-0.09 | $-0.14 | -55.6% | $5.94M | — |
Frequently asked questions
Has Cartesian Therapeutics Inc. beaten earnings estimates?
Cartesian Therapeutics Inc. has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -59.8% over the last 4 quarters.
How does RNAC stock react to earnings?
RNAC stock has moved an average of +13.7% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Cartesian Therapeutics Inc.'s revenue growth rate?
Cartesian Therapeutics Inc. reported year-over-year revenue growth of -224.8% in its most recent quarter, with EPS growing -356.0% year-over-year.